《Nature Biotechnology》报道北京大学药学院夏青教授团队开创性应用

中国药学(英文版) ›› 2022, Vol. 31 ›› Issue (3): 231-232.

《Nature Biotechnology》报道北京大学药学院夏青教授团队开创性应用"tRNA-酶"治疗无义突变罕见病的进展

北京大学药学院

北京大学药学院

收稿日期:2022-03-22 修回日期:2022-03-23 接受日期:2022-03-23 出版日期:2022-03-31 发布日期:2022-03-31

The progress of the pioneering application of "tRNA-enzyme" in the treatment of rare diseases with nonsense mutations has been reported in Nature Biotechnology by the group of Professor Qing Xia

School of Pharmaceutical Sciences, Peking University Health Science Center

School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2022-03-22 Revised:2022-03-23 Accepted:2022-03-23 Online:2022-03-31 Published:2022-03-31

摘要/Abstract

Supporting:

北京大学药学院. 《Nature Biotechnology》报道北京大学药学院夏青教授团队开创性应用"tRNA-酶"治疗无义突变罕见病的进展[J]. 中国药学(英文版), 2022, 31(3): 231-232.

School of Pharmaceutical Sciences, Peking University Health Science Center. The progress of the pioneering application of "tRNA-enzyme" in the treatment of rare diseases with nonsense mutations has been reported in Nature Biotechnology by the group of Professor Qing Xia[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(3): 231-232.